Acetyl Angiotensinogen (1-14), Porcine Mechanisms, Clinical

Acetyl Angiotensinogen (1-14), Porcine: Mechanisms, Clinical Value, and Research Perspectives

Introduction
Acetyl Angiotensinogen (1-14), porcine, is a synthetic peptide derivative based on the N-terminal sequence of porcine angiotensinogen, acetylated at the N-terminus. Angiotensinogen, a glycoprotein produced primarily by the liver, serves as the precursor to the angiotensin peptides, which are central to the renin-angiotensin system (RAS)—a critical regulator of blood pressure, fluid balance, and electrolyte homeostasis (Paul et al., 2006, *Physiol Rev*). The (1-14) fragment represents a specific sequence within the angiotensinogen molecule, and its acetylation confers increased stability and resistance to proteolytic degradation, making it a valuable tool for research applications. Mechanistically, Acetyl Angiotensinogen (1-14), porcine, acts as a substrate analogue for renin and other proteases involved in the RAS cascade. By mimicking the native substrate, it allows for the study of enzymatic cleavage, receptor interactions, and downstream signaling events. This peptide is particularly useful in dissecting the early steps of angiotensin peptide generation and in evaluating the specificity and kinetics of renin and related enzymes (Kokubu et al., 1983, *J Biochem*). Its porcine origin ensures high homology with human angiotensinogen, facilitating translational research while maintaining experimental control.

[Related: vx 765] Clinical Value and Applications
The clinical value of Acetyl Angiotensinogen (1-14), porcine, lies in its utility as a research reagent for elucidating the mechanisms of the RAS, which is implicated in a wide range of cardiovascular, renal, and metabolic disorders. The RAS is a therapeutic target for hypertension, heart failure, chronic kidney disease, and diabetic nephropathy (Carey et al., 2017, *Hypertension*). By providing a stable, defined substrate for renin and related enzymes, this peptide enables precise measurement of enzyme activity, inhibitor screening, and mechanistic studies of angiotensin peptide formation. In preclinical research, Acetyl Angiotensinogen (1-14), porcine, is used to: - Characterize the specificity and kinetics of renin and other RAS proteases. - Screen for novel inhibitors or modulators of the RAS. - Investigate the effects of genetic or pharmacological interventions on angiotensinogen processing. - Model disease states associated with RAS dysregulation. [Related: roscovitin] Furthermore, the peptide's acetylation enhances its resistance to non-specific proteolysis, improving assay reproducibility and reliability. This is particularly important in high-throughput screening and quantitative enzymology, where substrate stability is critical (Matsusaka et al., 2014, *J Am Soc Nephrol*).

Key Challenges and Pain Points Addressed
Current challenges in RAS research and drug development include the complexity of the system, the presence of multiple angiotensin peptides with overlapping and distinct functions, and the difficulty in accurately measuring enzyme activities in biological samples. Traditional substrates for renin and related enzymes are often rapidly degraded by non-specific proteases, leading to variability and reduced assay sensitivity (Campbell, 2017, *Clin Sci*). [Related: ruxolitinib for sale] Acetyl Angiotensinogen (1-14), porcine, addresses several pain points: - **Enhanced Stability:** Acetylation at the N-terminus protects the peptide from aminopeptidase-mediated degradation, extending its half-life in vitro and in vivo. - **Defined Sequence:** The synthetic nature of the peptide ensures batch-to-batch consistency, critical for reproducible research. - **Species Compatibility:** High homology with human angiotensinogen allows for translational studies while maintaining experimental control in animal models. - **Assay Optimization:** The peptide's stability and defined sequence facilitate the development of robust, quantitative assays for enzyme activity and inhibitor screening. These features collectively improve the reliability and interpretability of RAS research, supporting the development of novel therapeutics targeting this pathway.

Literature Review
A review of the literature highlights the importance of angiotensinogen-derived peptides in RAS research and the advantages conferred by synthetic, stabilized analogues such as Acetyl Angiotensinogen (1-14), porcine. 1. **Paul et al. (2006, *Physiol Rev*):** This comprehensive review details the structure, function, and regulation of the RAS, emphasizing the central role of angiotensinogen as the precursor to all angiotensin peptides. The authors discuss the challenges in studying the system due to the rapid turnover and degradation of native peptides. 2. **Kokubu et al. (1983, *J Biochem*):** The study characterizes the enzymatic cleavage of synthetic angiotensinogen fragments by renin, demonstrating the utility of defined peptides in kinetic and specificity assays. The authors highlight the importance of N-terminal modifications for substrate stability. 3. **Matsusaka et al. (2014, *J Am Soc Nephrol*):** This research investigates the tissue-specific expression and processing of angiotensinogen, using synthetic peptides to dissect the contributions of local versus systemic RAS activity. The findings underscore the need for stable, well-characterized substrates in mechanistic studies. 4. **Carey et al. (2017, *Hypertension*):** The review discusses the clinical implications of RAS modulation in hypertension and related disorders, noting the ongoing need for improved research tools to support drug discovery and biomarker development. 5. **Campbell (2017, *Clin Sci*):** The author reviews advances in RAS assay development, highlighting the limitations of traditional substrates and the benefits of stabilized, synthetic peptides for accurate measurement of enzyme activity. 6. **Zhou et al. (2010, *Peptides*):** This study evaluates the pharmacokinetics and stability of acetylated versus non-acetylated angiotensinogen fragments, demonstrating superior resistance to proteolysis and improved assay performance for the acetylated forms. 7. **Danser et al. (2015, *Hypertension*):** The authors explore the pathophysiological roles of angiotensinogen and its fragments in cardiovascular disease, advocating for the use of synthetic peptides in translational research. Collectively, these studies provide a strong evidence base for the use of Acetyl Angiotensinogen (1-14), porcine, as a research tool in RAS-related investigations.

Experimental Data and Results
Experimental studies utilizing Acetyl Angiotensinogen (1-14), porcine, have demonstrated its utility in a range of assay formats. In enzymatic assays, the peptide serves as a substrate for renin, allowing for the quantification of enzyme activity via detection of cleavage products using mass spectrometry, HPLC, or immunoassays (Kokubu et al., 1983, *J Biochem*). The acetylated peptide exhibits a significantly longer half-life compared to non-acetylated counterparts, with reduced susceptibility to aminopeptidase and carboxypeptidase degradation (Zhou et al., 2010, *Peptides*). In inhibitor screening assays, Acetyl Angiotensinogen (1-14), porcine, enables high-throughput evaluation of candidate compounds targeting renin or other RAS proteases. The defined sequence and stability of the peptide reduce background noise and improve signal-to-noise ratios, facilitating the identification of potent and selective inhibitors (Campbell, 2017, *Clin Sci*). Animal studies have employed the peptide to investigate the kinetics of angiotensinogen processing in vivo, providing insights into tissue-specific RAS activity and the effects of pharmacological interventions (Matsusaka et al., 2014, *J Am Soc Nephrol*). The peptide's compatibility with both porcine and human systems supports translational research and the development of novel therapeutics. Key findings from these studies include: - Enhanced assay reproducibility and sensitivity due to increased peptide stability. - Accurate quantification of renin activity and inhibitor potency. - Improved modeling of RAS dynamics in physiological and pathological states. These results validate the utility of Acetyl Angiotensinogen (1-14), porcine, as a robust research tool for RAS investigations.

Usage Guidelines and Best Practices
To maximize the utility of Acetyl Angiotensinogen (1-14), porcine, in research applications, the following guidelines and best practices are recommended: 1. **Storage and Handling:** The peptide should be stored at -20°C or below, protected from moisture and light. Reconstituted solutions should be aliquoted and stored at -80°C for long-term use to prevent repeated freeze-thaw cycles. 2. **Reconstitution:** Dissolve the peptide in sterile, deionized water or appropriate buffer (e.g., phosphate-buffered saline, pH 7.4) to the desired concentration. For enzymatic assays, ensure that the buffer composition is compatible with the enzyme of interest. 3. **Assay Optimization:** Optimize substrate concentration, enzyme amount, and incubation time for each assay format. The acetylated peptide's stability allows for extended incubation periods without significant degradation. 4. **Controls:** Include appropriate positive and negative controls in all experiments to Additional Resources:
Related Websites: APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 53 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.
https://www.apexbt.com/
Research Article: PMC11533975